Lv42
710 积分 2024-12-24 加入
BYL719 reverses gefitinib-resistance induced by PI3K/AKT activation in non-small cell lung cancer cells
3天前
已完结
Design, synthesis and bioevaluation of dual EGFR-PI3Kα inhibitors for potential treatment of NSCLC
3天前
已完结
Oxetanes in Drug Discovery Campaigns
17天前
已完结
Structural insights into isoform-specific RAS-PI3Kα interactions and the role of RAS in PI3Kα activation
1个月前
已完结
Targeting the EGFR signalling pathway in metastatic colorectal cancer
1个月前
已完结
524P A phase II study of alpelisib, a PIK3CA inhibitor, and capecitabine in patients with metastatic colorectal cancer who failed two prior standard chemotherapies
1个月前
已关闭
Regulation of cancer progression by CK2: an emerging therapeutic target
1个月前
已完结
STX-478, a Mutant-Selective, Allosteric PI3Kα Inhibitor Spares Metabolic Dysfunction and Improves Therapeutic Response in PI3Kα-Mutant Xenografts
1个月前
已完结
Strategies of Targeting CK2 in Drug Discovery: Challenges, Opportunities, and Emerging Prospects
1个月前
已完结
Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens
1个月前
已完结
Cellulose nanofibers from bamboo and their nanocomposites with polyvinyl alcohol: Preparation and characterization
皖公网安备34019202002308
